Toby H. Cox

491 total citations
12 papers, 340 citations indexed

About

Toby H. Cox is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toby H. Cox has authored 12 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 5 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toby H. Cox's work include Infant Development and Preterm Care (3 papers), Neonatal Respiratory Health Research (3 papers) and Pneumonia and Respiratory Infections (2 papers). Toby H. Cox is often cited by papers focused on Infant Development and Preterm Care (3 papers), Neonatal Respiratory Health Research (3 papers) and Pneumonia and Respiratory Infections (2 papers). Toby H. Cox collaborates with scholars based in United States. Toby H. Cox's co-authors include Shelley C. Springer, Thomas C. Hulsey, Stephen D. Kicklighter, Ronald B. Turner, Sandra S. Garner, Carol L. Wagner, Lakshmi D. Katikaneni, Rita M. Ryan, David J. Annibale and Eugene Chang and has published in prestigious journals such as PEDIATRICS, The Journal of Pediatrics and Vaccine.

In The Last Decade

Toby H. Cox

12 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toby H. Cox United States 7 150 133 108 98 90 12 340
Smadar Eventov Friedman Israel 12 190 1.3× 137 1.0× 81 0.8× 91 0.9× 179 2.0× 29 390
Eleni Agakidou Greece 13 120 0.8× 191 1.4× 44 0.4× 189 1.9× 125 1.4× 42 586
A Collinson United Kingdom 5 365 2.4× 135 1.0× 46 0.4× 68 0.7× 205 2.3× 9 502
Orna Flidel‐Rimon Israel 17 194 1.3× 244 1.8× 97 0.9× 241 2.5× 292 3.2× 38 719
Kim An Nguyen France 11 65 0.4× 125 0.9× 47 0.4× 115 1.2× 203 2.3× 30 466
Shelley C. Springer United States 6 194 1.3× 96 0.7× 150 1.4× 87 0.9× 104 1.2× 10 524
Rubens Feferbaum Brazil 11 115 0.8× 68 0.5× 34 0.3× 72 0.7× 59 0.7× 32 359
Prem Fort United States 6 293 2.0× 166 1.2× 51 0.5× 193 2.0× 201 2.2× 16 519
Albert Akierman Canada 11 63 0.4× 149 1.1× 91 0.8× 207 2.1× 64 0.7× 37 466
Mary Naples United States 5 102 0.7× 106 0.8× 25 0.2× 141 1.4× 98 1.1× 5 364

Countries citing papers authored by Toby H. Cox

Since Specialization
Citations

This map shows the geographic impact of Toby H. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby H. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby H. Cox more than expected).

Fields of papers citing papers by Toby H. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby H. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby H. Cox. The network helps show where Toby H. Cox may publish in the future.

Co-authorship network of co-authors of Toby H. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Toby H. Cox. A scholar is included among the top collaborators of Toby H. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby H. Cox. Toby H. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cox, Toby H., et al.. (2023). First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic. Vaccine. 41(17). 2824–2828. 6 indexed citations
2.
Cox, Toby H., et al.. (2022). Implementation of a Standardized Premedication Bundle to Improve Procedure Success for Nonemergent Neonatal Intubations. Pediatric Quality and Safety. 8(1). e622–e622. 2 indexed citations
4.
Wiest, Donald B., et al.. (2014). Antenatal Pharmacokinetics and Placental Transfer of N-Acetylcysteine in Chorioamnionitis for Fetal Neuroprotection. The Journal of Pediatrics. 165(4). 672–677.e2. 38 indexed citations
5.
Mueller, Martina, Toby H. Cox, John Cahill, et al.. (2013). Antibiotic Timing in Neonates With Suspected Hospital-Acquired Infections. Advances in Neonatal Care. 13(1). 22–28. 18 indexed citations
6.
Garner, Sandra S. & Toby H. Cox. (2012). Lucinactant: New and Approved, But Is It an Improvement?. The Journal of Pediatric Pharmacology and Therapeutics. 17(3). 206–210. 3 indexed citations
7.
Garner, Sandra S., et al.. (2009). Gabapentin Therapy for Pain and Irritability in a Neurologically Impaired Infant. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(8). 997–1001. 18 indexed citations
8.
Annibale, David J., et al.. (2002). Discharge planning for very low birthweight infants.. PubMed. 98(3). 145–54. 1 indexed citations
9.
Kicklighter, Stephen D., Shelley C. Springer, Toby H. Cox, Thomas C. Hulsey, & Ronald B. Turner. (2001). Fluconazole for Prophylaxis Against Candidal Rectal Colonization in the Very Low Birth Weight Infant. PEDIATRICS. 107(2). 293–298. 180 indexed citations
10.
Wagner, Carol L., et al.. (2000). Early Discharge With Home Antibiotic Therapy in the Treatment of Neonatal Infection. Journal of Perinatology. 20(6). 346–350. 13 indexed citations
11.
Wagner, Carol L., Lakshmi D. Katikaneni, Toby H. Cox, & Rita M. Ryan. (1998). THE IMPACT OF PRENATAL DRUG EXPOSURE ON THE NEONATE. Obstetrics and Gynecology Clinics of North America. 25(1). 169–194. 48 indexed citations
12.
Cox, Toby H., G. Mark Baillie, & Prabhakar K. Baliga. (1997). Bradycardia Associated with Intravenous Administration of Tacrolimus in a Liver Transplant Recipient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(6). 1328–1330. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026